Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5000)
All Articles published online
|
Publishing Process of This Article
|
Oct 28, 2021 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ahumada A, Rayón L, Usón C, Bañares R, Alonso Lopez S. Hepatocellular carcinoma risk after viral response in hepatitis C virus-advanced fibrosis: Who to screen and for how long? World J Gastroenterol 2021; 27(40): 6737-6749 [PMID: 34790004 DOI: 10.3748/wjg.v27.i40.6737] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v27/i40/6737.htm |
| Number | Citing Articles |
| 1 |
Ashraf Elbahrawy, Hassan Atalla, Abdulla A. Mahmoud, Ahmed Eliwa, Alaa Alsawak, Mohamed Alboraie, Ali Madian, Ahmed Alashker, Sadek Mostafa, Ahmed Alwassief, Hussein H. Aly. Prediction and surveillance of de novo HCC in patients with compensated advanced chronic liver disease after hepatitis C virus eradication with direct antiviral agents. Frontiers in Virology 2023; 3 doi: 10.3389/fviro.2023.1227317
|
| 2 |
Christine C Hsu, Harish Gopalakrishna, Maria Mironova, Mei-Hsuan Lee, Chien-Jen Chen, Hwai-I Yang, Manfred Wiese, Kyong-Mi Chang, Elizabeth C Wright, Tomilowo Abijo, Jordan J Feld, David E Kaplan. Risk of Hepatocellular Carcinoma After Spontaneous Clearance of Hepatitis C Virus and in Noncirrhosis Chronic Hepatitis C Patients With Sustained Virological Response: A Systematic Review. Clinical Infectious Diseases 2023; 77(Supplement_3): S245 doi: 10.1093/cid/ciad380
|
| 3 |
Ester Badami, Rosalia Busà, Bruno Douradinha, Giovanna Russelli, Vitale Miceli, Alessia Gallo, Giovanni Zito, Pier Giulio Conaldi, Gioacchin Iannolo. Hepatocellular carcinoma, hepatitis C virus infection and miRNA involvement: Perspectives for new therapeutic approaches. World Journal of Gastroenterology 2022; 28(22): 2417-2428 doi: 10.3748/wjg.v28.i22.2417
|
| 4 |
Takako Inoue, Yasuhito Tanaka. Comprehensive Guide to Hepatitis Advances. 2023; : 31 doi: 10.1016/B978-0-323-98368-6.00009-4
|
| 5 |
Xiao-He Li, Rui Huang, Ming Yang, Jian Wang, Ying-Hui Gao, Qian Jin, Dan-Li Ma, Lai Wei, Hui-Ying Rao. Gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced magnetic resonance imaging for evaluating fibrosis regression in chronic hepatitis C patients after direct-acting antiviral. World Journal of Gastroenterology 2022; 28(20): 2214-2226 doi: 10.3748/wjg.v28.i20.2214
|
| 6 |
Silvia Espina Cadena, Diego Casas Deza, Belén Julián Gomara, Cristina Victoria Borao Laguna, Olivia Sierra Gabarda, Luis Javier Lamuela Calvo, Sara Lorente, Trinidad Serrano, José Miguel Arbonés Mainar, Vanesa Bernal Monterde. Screening and risk of hepatocellular carcinoma in patients with advanced fibrosis after hepatitis C virus eradication. Revista Española de Enfermedades Digestivas 2024; doi: 10.17235/reed.2024.9945/2023
|
| 7 |
Sugan Panneerselvam, Cornelia Wilson, Prem Kumar, Dinu Abirami, Jayakrishna Pamarthi, Mettu Srinivas Reddy, Joy Varghese. Overview of hepatocellular carcinoma: from molecular aspects to future therapeutic options. Cell Adhesion & Migration 2023; 17(1): 1 doi: 10.1080/19336918.2023.2258539
|
| 8 |
Francesco Paolo Russo, Alberto Zanetto, Elisa Pinto, Sara Battistella, Barbara Penzo, Patrizia Burra, Fabio Farinati. Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand?. International Journal of Molecular Sciences 2022; 23(1): 500 doi: 10.3390/ijms23010500
|
| 9 |
Ester Badami, Claudia Carcione, Cinzia Maria Chinnici, Rosaria Tinnirello, Pier Giulio Conaldi, Gioacchin Iannolo. HCV Interplay With Mir34a: Implications in Hepatocellular Carcinoma. Frontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.803278
|
| 10 |
Kazuto Tajiri, Hiroyuki Ito, Kengo Kawai, Yoshiro Kashii, Yuka Hayashi, Aiko Murayama, Masami Minemura, Terumi Takahara, Yukihiro Shimizu, Ichiro Yasuda. Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma. World Journal of Hepatology 2022; 14(6): 1190-1199 doi: 10.4254/wjh.v14.i6.1190
|
| 11 |
Alessia Ciancio, Davide Giuseppe Ribaldone, Matteo Spertino, Alessandra Risso, Debora Ferrarotti, Gian Paolo Caviglia, Patrizia Carucci, Silvia Gaia, Emanuela Rolle, Marco Sacco, Giorgio Maria Saracco. Who Should Not Be Surveilled for HCC Development after Successful Therapy with DAAS in Advanced Chronic Hepatitis C? Results of a Long-Term Prospective Study. Biomedicines 2023; 11(1): 166 doi: 10.3390/biomedicines11010166
|